Literature DB >> 30737301

Brain Access of Monoclonal Antibodies as Imaged and Quantified by 89Zr-Antibody PET: Perspectives for Treatment of Brain Diseases.

Sophie E M Veldhuijzen van Zanten1,2, Philip C De Witt Hamer3, Guus A M S van Dongen4.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 30737301     DOI: 10.2967/jnumed.118.220939

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  7 in total

1.  The blood-brain barrier limits the therapeutic efficacy of antibody-drug conjugates in glioblastoma.

Authors:  Roger Abounader; David Schiff
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 13.029

Review 2.  The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.

Authors:  Ilanah J Pruis; Guus A M S van Dongen; Sophie E M Veldhuijzen van Zanten
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

3.  IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.

Authors:  Haritha L Desu; Melanie Plastini; Placido Illiano; Helen M Bramlett; W Dalton Dietrich; Juan Pablo de Rivero Vaccari; Roberta Brambilla; Robert W Keane
Journal:  J Neuroinflammation       Date:  2020-05-04       Impact factor: 8.322

4.  Biodistribution Analysis of an Anti-EGFR Antibody in the Rat Brain: Validation of CSF Microcirculation as a Viable Pathway to Circumvent the Blood-Brain Barrier for Drug Delivery.

Authors:  Ghazal Naseri Kouzehgarani; Pankaj Kumar; Susan E Bolin; Edward B Reilly; Didier R Lefebvre
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525

5.  Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice.

Authors:  Marion Chomet; Maxime Schreurs; Ricardo Vos; Mariska Verlaan; Esther J Kooijman; Alex J Poot; Ronald Boellaard; Albert D Windhorst; Guus Ams van Dongen; Danielle J Vugts; Marc C Huisman; Wissam Beaino
Journal:  EJNMMI Res       Date:  2021-06-12       Impact factor: 3.138

6.  Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review.

Authors:  Sajjad Muhammad; Shafqat Rasul Chaudhry; Ulf Dietrich Kahlert; Martin Lehecka; Miikka Korja; Mika Niemelä; Daniel Hänggi
Journal:  Int J Mol Sci       Date:  2020-04-14       Impact factor: 5.923

Review 7.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.